BioStem Technologies, Inc. (BSEM) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $17.84K; Additional Paid in CapitalUSD $66.61M; Treasury Stock, ValueUSD $43.35K; Retained Earnings (Accumulated Deficit)USD $-38.97M.
- 2026-03-31: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD (m); Treasury Stock, ValueUSD (m); Retained Earnings (Accumulated Deficit)USD (m).
- 2025-12-31: Common Stock, Value, IssuedUSD $16.83K; Additional Paid in CapitalUSD $60.34M; Treasury Stock, ValueUSD $43.35K; Retained Earnings (Accumulated Deficit)USD $-21.17M.
- 2025-06-30: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD (m); Treasury Stock, ValueUSD (m); Retained Earnings (Accumulated Deficit)USD (m).
BioStem Technologies, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Value USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.84K | $66.61M | $43.35K | $-38.97M | $27.61M | 18.00K | 3 month · $1.00M 6 month · $1.67M |
| 2026-03-31 | (m) | (m) | (m) | (m) | $31.87M | (m) | (m) |
| 2025-12-31 | $16.83K | $60.34M | $43.35K | $-21.17M | $39.14M | 18.00K | 12 month · $3.23M |
| 2025-06-30 | (m) | (m) | (m) | (m) | $47.23M | (m) | 3 month · $495.87K 6 month · $2.23M |
| 2025-03-31 | (m) | (m) | (m) | (m) | $46.09M | (m) | (m) |
| 2024-12-31 | $16.66K | $54.64M | $43.35K | $-14.59M | $40.02M | 18.00K | 12 month · $6.30M |
| 2023-12-31 | (m) | (m) | (m) | (m) | $-1.34M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |